THE COMBINATION OF SORAFENIB AND CAPECITABINE IN RECURRENT FIBROLAMELLAR HEPATOCELLULAR CARCINOMA: A NOVEL ORAL CHEMOTHERAPY APPROACH

Han Jennifer; McKee Jason; Richards Allyson; Patt Yehuda; Kuttesch John

首页> 外文期刊>Pediatric blood & cancer >THE COMBINATION OF SORAFENIB AND CAPECITABINE IN RECURRENT FIBROLAMELLAR HEPATOCELLULAR CARCINOMA: A NOVEL ORAL CHEMOTHERAPY APPROACH

【24h】

THE COMBINATION OF SORAFENIB AND CAPECITABINE IN RECURRENT FIBROLAMELLAR HEPATOCELLULAR CARCINOMA: A NOVEL ORAL CHEMOTHERAPY APPROACH

机译：索拉非尼和卡押沙明在复发性纤维素肝细胞癌中的组合：一种新型口腔化疗方法

获取原文

获取原文并翻译 | 示例

获取外文期刊封面封底 >>

开具论文收录证明 >>

文献代查 >>

团队文献服务 >>

页面导航

著录项
引文网络
相似文献
相关主题

著录项

来源
《Pediatric blood & cancer》 |2018年第1期|共1页
作者
Han Jennifer; McKee Jason; Richards Allyson; Patt Yehuda; Kuttesch John;
展开▼
作者单位

Univ New Mexico Albuquerque NM 87131 USA;

Univ New Mexico Albuquerque NM 87131 USA;

Univ New Mexico Albuquerque NM 87131 USA;

Univ New Mexico Albuquerque NM 87131 USA;

Univ New Mexico Albuquerque NM 87131 USA;

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类儿科学;
关键词

相似文献

外文文献
中文文献
专利

1. THE COMBINATION OF SORAFENIB AND CAPECITABINE IN RECURRENT FIBROLAMELLAR HEPATOCELLULAR CARCINOMA: A NOVEL ORAL CHEMOTHERAPY APPROACH [J] . Han Jennifer, McKee Jason, Richards Allyson, Pediatric blood & cancer . 2018,第Suppla1期

机译：索拉非尼和卡押沙明在复发性纤维素肝细胞癌中的组合：一种新型口腔化疗方法
2. Phase II Trial of Sorafenib in Combination with Capecitabine in Patients with Hepatocellular Carcinoma: INST 08a??20 [J] . Yehuda Patt, Cristhiam Rojasa??Hernandez, Houman Mohammad Fekrazad, The oncologist . 2017,第10期

机译：索拉非尼联合卡培他滨治疗肝细胞癌的II期临床试验：INST 08a ?? 20
3. Phase II Trial of Sorafenib in Combination with Capecitabine in Patients with Hepatocellular Carcinoma: INST 08-20 [J] . Patt Yehuda, Rojas-Hernandez Cristhiam, Fekrazad Houman Mohammad, The oncologist . 2017,第10期

机译：Sorafenib的II期试验与肝细胞癌患者的Capecitabine结合：08-20
4. Diffusion-weighted MR imaging of advanced hepatocellular carcinoma treated with the oral multikinase inhibitor Sorafenib [C] . C. Schraml, N.F. Schwenzer, H. Rempp, World congress on medical physics and biomedical engineering;International congress of the IUPESM . 2011

机译：口服多激酶抑制剂索拉非尼治疗晚期肝癌的扩散加权MR成像
5. Cyclic AMP Dependent Protein Kinase A (PKA) Mutant Associated with Fibrolamellar Hepatocellular Carcinoma (FLHCC): Structure, Dynamics and in Cell Studies [D] . Karamafrooz, Adak. 2020

机译：与纤维素肝细胞癌（FLHCC）相关的循环AMP依赖性蛋白激酶A（PKA）突变体：结构，动力学和细胞研究
6. Phase II Trial of Sorafenib in Combination with Capecitabine in Patients with Hepatocellular Carcinoma: INST 08‐20 [O] . Yehuda Patt, Cristhiam Rojas‐Hernandez, Houman Mohammad Fekrazad, 2017

机译：索拉非尼联合卡培他滨治疗肝细胞癌的II期临床试验：INST 08-20
7. Arsenic trioxide plus cisplatin/interferon α-2b/doxorubicin/capecitabine combination chemotherapy for unresectable hepatocellular carcinoma [O] . Tomuleasa Ciprian, Soritau Olga, Fischer-Fodor Eva, 2011

机译：三氧化二砷加顺铂/干扰素α-2b/阿霉素/卡培他滨联合化疗治疗无法切除的肝细胞癌

THE COMBINATION OF SORAFENIB AND CAPECITABINE IN RECURRENT FIBROLAMELLAR HEPATOCELLULAR CARCINOMA: A NOVEL ORAL CHEMOTHERAPY APPROACH

著录项

引文网络

相似文献

相关主题

期刊订阅